Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20121
20141
20171
20183
20202
20212
20222
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed5
Active, not recruiting3
Unknown status2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
National Taiwan University Hospital2
Novartis Pharmaceuticals2
BeiGene1
Bristol-Myers Squibb1
China Medical University Hospital1
Daiichi Sankyo1
DualityBio Inc.1
Eli Lilly and Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms20
Carcinoma, Non-Small-Cell Lung5
Stomach Neoplasms4
Cholangiocarcinoma3
Neoplasms3
Endometrial Neoplasms2
Lung Neoplasms2
Ovarian Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Triple Negative Breast Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.